Chasing My Cure author David Fajgenbaum M13 WG15 shares five life lessons learned from his battle with Castleman disease that resonate during the coronavirus pandemic.
New must-reads explore the secrets of resilient entrepreneurs, the business value of aesthetics, and one man’s mission to cure his own rare disease.
One doctor's quest to cure his own disease, best practices for aspiring entrepreneurs, and a look at how established companies can foster startup-like innovation
A dose of business principles, in large part from venture philanthropy, is changing the way medical research is done in the U.S. health care industry.
David Fajgenbaum is battling a little-known, extremely deadly disease as a researcher, a physician, an advocate, an entrepreneur and a patient.
There are myriad examples of the expanding public and social role of the private sector, including those of Wharton alumni David Fajgenbaum and Elon Musk.